Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AstraZeneca and iRhythm Technologies and Encourages Investors to Contact the Firm
NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of AstraZeneca PLC (NASDAQ: AZN) and iRhythm Technologies, Inc. (NASDAQ: IRTC). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. AstraZeneca PLC (NASDAQ: AZN) Class Pe...
Astrazeneca Plc Irhythm Technologies Clinical Trial Class Period Nationally Recognized Trial Results
Source: yahoo.com